TRXB
NASD TRex Bio, Inc.$13.41 ↓ -0.59 (-4.21%) Trading Down from the previous close of $14.00
- YTD change
- -4.21%
- vs 20-day SMA
- N/A
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.00 (+0.00%) / 6M
No chart data available
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 13.5% away from all-time highs of $15.50
- TRXB is down 4% since the beginning of the year
- TRXB is down 4% over the past 12 months
- TRXB is down 4% over the past 1 month
- Previous minute
- +$0.00
- Last hour
- -$0.06
- Last 5 days
- -4.21%
- vs 8-day SMA
- N/A
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
TRexBio is a biotechnology company that leverages cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop therapeutics for cancer and inflammatory diseases. Its 'deep biology' discovery engine maps human tissue Treg behavior to disease processes, identifying and characterizing novel targets for therapeutic intervention. The platform supports the development of a portfolio of therapies that modulate the immune system to restore tissue immune homeostasis.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.